By Rachel Slajda ( May 10, 2013, 7:07 PM EDT) -- The drug industry is using a Second Circuit ruling that blocked the U.S. Food and Drug Administration from prosecuting a salesman for promoting a drug for off-label uses to push the agency to adopt regulations that would allow for truthful off-label marketing, hoping the change would significantly boost drug sales....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.